Hookipa Pharma Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 39 institutions reported holding Hookipa Pharma Inc. in their 13F filings, down 8 from Q1 2024. 6 opened new positions and 14 sold out. The largest holders were EcoR1 Capital, LLC ($3.4M), Artal Group S.A. ($3.4M) and Knoll Capital Management, LLC ($3.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Hookipa Pharma Inc.
- CUSIP
- 43906K100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $88K |
| Exits | 14 | $6.5M |
All 13F filers, Q1 2024 → Q2 2024: 1,691,976 shares bought and 10,440,909 shares sold, net −8,748,933 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| EcoR1 Capital, LLC | 0.10% | Add +24.4% | 5,717,324 | $3.4M |
| Artal Group S.A. | 0.09% | No change | 5,666,410 | $3.4M |
| Knoll Capital Management, LLC | 2.20% | No change | 5,517,385 | $3.3M |
| FMR LLC | 0.00% | Add +1.4% | 3,404,001 | $2.0M |
| Vanguard Group Inc. | 0.00% | Add +0.1% | 2,120,473 | $1.3M |
| Redmile Group, LLC | 0.04% | No change | 1,063,769 | $630K |
| Acadian Asset Management LLC | 0.00% | Add +12.3% | 991,106 | $586K |
| Geode Capital Management, LLC | 0.00% | Add +6.5% | 707,828 | $419K |
| Renaissance Technologies | 0.00% | Add +38.4% | 302,246 | $179K |
| Morgan Stanley | 0.00% | Reduce -81.0% | 235,920 | $140K |
| Royal Bank of Canada | 0.00% | Add +2.4% | 215,435 | $127K |
| State Street Corp. | 0.00% | Add +5.9% | 169,690 | $100K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 156,630 | $93K |
| BlackRock Inc. | 0.00% | Reduce -56.9% | 124,672 | $74K |
| Two Sigma Investments, LP | 0.00% | Add +28.2% | 121,469 | $72K |
| Gsa Capital Partners LLP | 0.01% | New | 119,637 | $71K |
| Prudential Financial Inc. | 0.00% | No change | 64,600 | $38K |
| Group One Trading LLC | 0.00% | Add +239.0% | 59,004 | $35K |
| Susquehanna International Group, LLP | 0.00% | Reduce -71.8% | 50,642 | $30K |
| Tyler-Stone Wealth Management | 0.01% | Add +0.5% | 47,390 | $28K |
| Two Sigma Advisers, LP | 0.00% | Add +31.7% | 46,900 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +307.7% | 42,609 | $25K |
| Millennium Management | 0.00% | Reduce -2.5% | 40,137 | $24K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +0.3% | 36,413 | $22K |
| Jane Street Group, LLC | 0.00% | Add +35.5% | 35,242 | $21K |
| Two Sigma Securities, LLC | 0.00% | New | 16,314 | $10K |
| International Assets Investment Management, LLC | 0.00% | No change | 14,000 | $8K |
| Ground Swell Capital, LLC | 0.01% | New | 12,471 | $7K |
| Bank of America Corp. | 0.00% | Reduce -14.4% | 5,480 | $3K |
| Lanark Financial, Inc. | 0.00% | No change | 6,000 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +3.8% | 4,150 | $2K |
| BNP Paribas Financial Markets | 0.00% | No change | 337 | $199 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 330 | $195 |
| Global Retirement Partners, LLC | 0.00% | New | 300 | $178 |
| Citigroup Inc. | 0.00% | No change | 74 | $44 |
| UBS Group AG | 0.00% | Reduce -99.5% | 64 | $38 |
| JPMorgan Chase & Co. | 0.00% | No change | 14 | $8 |
| Qube Research & Technologies Ltd | 0.00% | New | 4 | $2 |
| Lazard Asset Management LLC | 0.00% | New | 1,249 | $0 |
"% of holder's portfolio" is HOOKIPA PHARMA INC's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.